Skip to main content
logo
OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.385
+0.005 (0.36%)
At close: Sep 25, 2026, 4:00 PM EDT
1.380
-0.005 (-0.36%)
After-hours: Sep 25, 2026, 7:30 PM EDT

OKYO Pharma Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal QuarterQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingMar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Gross Profit
-6.69-6.48-6.26-5.55-4.84-4.67-4.49-6-7.51-7.79
Operating Income
-8.5-7.38-6.25-6.67-7.09-8.72-10.35-13.05-15.75-16.09
Net Income
-8.95-6.78-4.61-4.66-4.71-7.7-10.69-13.76-16.83-16.71
Earnings Per Share
-0.24-0.17-0.11-0.12-0.12-0.21-0.32-0.44-0.57-0.62
EPS Growth
----------

Cash & Debt
Chart
Fiscal QuarterQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingMar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Cash & Investments
20.5920.594.224.221.561.560.990.990.830.83
Total Debt
--0.190.19--00--
Net Cash (Debt)
20.5920.594.034.031.561.560.990.990.830.83
Net Cash Growth
1219.38%1219.38%309.44%309.44%88.78%88.78%--46.16%--
Net Cash Per Share
0.550.520.100.100.040.040.030.030.030.03

Cash Flow & CapEx
Chart
Fiscal QuarterQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingMar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Operating Cash Flow
-5.94-4.52-3.1-2.45-1.81-2.37-2.94-6.21-9.49-10.24
Capital Expenditures
-0.01-0-0-0-0-0----0
Free Cash Flow
-5.94-4.52-3.1-2.46-1.81-2.38-2.94-6.21-9.49-10.24
Free Cash Flow Growth
----------

Valuation
Selected indicators aren't available for this stock.